{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:28:22Z","timestamp":1759336102667,"version":"build-2065373602"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009568","name":"Universidade Estadual Paulista","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/23357-5"],"award-info":[{"award-number":["2018\/23357-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.neuint.2022.105401","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T12:00:33Z","timestamp":1657713633000},"page":"105401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Insights for Alzheimer's disease pharmacotherapy and current clinical trials"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0959-6050","authenticated-orcid":false,"given":"A.L.C.S.","family":"Nascimento","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.P.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.S.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Frigieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Chorilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2022.105401_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/17425247.2018.1471058","article-title":"Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region","volume":"15","author":"Agrawal","year":"2018","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.neuint.2022.105401_bib2","article-title":"[P2-036]: The role of Epigallocatechin-3-Gallate, Coenzyme Q10 and Vinpocetine combination in providing protection together with mental and physical activities against Alzheimer's disease-associated risk factors in rats","volume":"13","author":"Ali","year":"2017","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2022.105401_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lfs.2019.05.006","article-title":"Physical & mental activities enhance the neuroprotective effect of vinpocetine & coenzyme Q10 combination against Alzheimer & bone remodeling in rats","volume":"229","author":"Ali","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2022.105401_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.621773","article-title":"Impact of SARS-CoV-2 infection on cognitive function: a systematic review","volume":"11","author":"Alnefeesi","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuint.2022.105401_bib5","first-page":"1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006"},{"key":"10.1016\/j.neuint.2022.105401_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgfs.2021.100329","article-title":"Fatty acid in raw and heated coconut oil in eleven coconut oil food preparations analysed by gas chromatography","volume":"24","author":"Azevedo","year":"2021","journal-title":"Int. J. Gastron. Food Sci."},{"key":"10.1016\/j.neuint.2022.105401_bib7","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ana.22333","article-title":"Amyloid\u2010\u03b2 associated cortical thinning in clinically normal elderly","volume":"69","author":"Becker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105401_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2020.00051","article-title":"Ischemia-triggered glutamate excitotoxicity from the perspective of glial cells","volume":"14","author":"Belov Kirdajova","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2022.105401_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.npp.1301193","article-title":"Intranasal insulin improves memory in humans: superiority of insulin aspart","volume":"32","author":"Benedict","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2022.105401_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","article-title":"The genetics of alzheimer disease: back to the future","volume":"68","author":"Bertram","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2022.105401_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijbiomac.2014.03.022","article-title":"Donepezil nanosuspension intended for nose to brain targeting: in vitro and in vivo safety evaluation","volume":"67","author":"Bhavna","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuint.2022.105401_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2016.06.1207","article-title":"P2-003: clinical trial design of cread: a randomized, double-blind, placebo-controlled, parallel-group phase 3 study to evaluate crenezumab treatment in patients with prodromal-to-mild Alzheimer's disease","volume":"12","author":"Blaettler","year":"2016","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2022.105401_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nano.2011.03.008","article-title":"Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues","volume":"7","author":"Brambilla","year":"2011","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.neuint.2022.105401_bib14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s40261-017-0549-5","article-title":"Pharmacokinetics of cromolyn and ibuprofen in healthy elderly volunteers","volume":"37","author":"Brazier","year":"2017","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.neuint.2022.105401_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/bs.apha.2016.02.003","article-title":"Excitotoxicity as a common mechanism for fetal neuronal injury with hypoxia and intrauterine inflammation","author":"Burd","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105401_bib16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2022.105401_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early\u2010onset Alzheimer's disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2022.105401_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer's disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2022.105401_bib19","first-page":"521","article-title":"Nanotecnologia em medicina: aspectos fundamentais e principais preocupa\u00e7\u00f5es [Nanotechnology in medicine: concepts and concerns]","volume":"37","author":"Cancino","year":"2014","journal-title":"Quim. Nova"},{"key":"10.1016\/j.neuint.2022.105401_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.neuint.2022.105401_bib21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3233\/JAD-160701","article-title":"AZD3293: Pharmacokinetic and pharmacodynamic effects in healthy subjects and patients with Alzheimer's disease","volume":"55","author":"Cebers","year":"2016","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2022.105401_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111209","article-title":"Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer's disease","volume":"186","author":"Chatterjee","year":"2020","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.neuint.2022.105401_bib23","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1021\/acsnano.7b07625","article-title":"Tau-targeted multifunctional nanocomposite for combinational therapy of Alzheimer's disease","volume":"12","author":"Chen","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.neuint.2022.105401_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9010094","article-title":"Host calcium channels and pumps in viral infections","volume":"9","author":"Chen","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neuint.2022.105401_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1212\/WNL.0b013e318246d67a","article-title":"Accelerated cortical atrophy in cognitively normal elderly with high -amyloid deposition","volume":"78","author":"Chetelat","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105401_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2015.00130","article-title":"Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease","volume":"7","author":"Christensen","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2022.105401_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3233\/JAD-122308","article-title":"Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease","volume":"35","author":"Claxton","year":"2013","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2022.105401_bib28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and alzheimer disease dementia","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuint.2022.105401_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/BF02562227","article-title":"Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain","author":"Crawford","year":"1999"},{"key":"10.1016\/j.neuint.2022.105401_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","article-title":"Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease","volume":"17","author":"Cumbo","year":"2010","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuint.2022.105401_bib31","first-page":"1","article-title":"Alzheimer's disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.neuint.2022.105401_bib32","first-page":"3","article-title":"Recent developments of nanotechnology for alzheimer \u2019 s disease diagnosis and therapy iron oxide NPs","volume":"4","author":"Dai","year":"2018","journal-title":"Glob. J. Nanomedicine"},{"key":"10.1016\/j.neuint.2022.105401_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2019.107082","article-title":"Improvement of memory deficits in the rat model of Alzheimer's disease by erythropoietin-loaded solid lipid nanoparticles","volume":"166","author":"Dara","year":"2019","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuint.2022.105401_bib34","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/alz.12255","article-title":"The chronic neuropsychiatric sequelae of COVID-19: the need for a prospective study of viral impact on brain functioning","volume":"17","author":"de Erausquin","year":"2021","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2022.105401_bib35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/jnc.15039","article-title":"Protective actions of exercise-related FNDC5\/Irisin in memory and Alzheimer's disease","volume":"155","author":"de Freitas","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105401_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.110917","article-title":"Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytes cell culture","volume":"515","author":"de Oliveira","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.neuint.2022.105401_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040933","article-title":"Obesity as a risk factor for severe covid-19 and complications: a review","author":"Demeulemeester","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuint.2022.105401_bib38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamaneurol.2013.1062","article-title":"Cross-sectional and longitudinal analysis of the relationship between A\u03b2 deposition, cortical thickness, and memory in cognitively unimpaired individuals and in alzheimer disease","volume":"70","author":"Dor\u00e9","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuint.2022.105401_bib39","first-page":"1","article-title":"Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8","volume":"2","author":"Duncan","year":"2022","journal-title":"ORF10 and M protein"},{"key":"10.1016\/j.neuint.2022.105401_bib40","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer's disease","volume":"380","author":"Egan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2022.105401_bib41","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1002\/jps.24557","article-title":"Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer's disease: optimization, biological efficacy, and potential toxicity","volume":"104","author":"Elnaggar","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.neuint.2022.105401_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0925-4439(95)00028-3","article-title":"BB Biochi \u223cmi c\u223ca et Biophysica \u00c3ta Biochemical, physiological and medical aspects of ubiquinone function","volume":"1271","author":"Ernster","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2022.105401_bib43","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts \u03b2-amyloid induced neuroinflammation by suppressing IL-1\u03b2 and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105401_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.neuint.2022.105401_bib45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","article-title":"Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting","volume":"47","author":"Fazil","year":"2012","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.neuint.2022.105401_bib46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/joim.12166","article-title":"Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study","volume":"275","author":"Freund Levi","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neuint.2022.105401_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neurobiolaging.2019.03.001","article-title":"The effects of omega-3 fatty acid deficiency during development on oxidative fatty acid degradation during maturity in a mouse model of Alzheimer's disease","volume":"79","author":"Furman","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2022.105401_bib48","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00401-021-02263-w","article-title":"Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer's disease","volume":"141","author":"Gerrits","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2022.105401_bib49","doi-asserted-by":"crossref","first-page":"E205","DOI":"10.1152\/ajpendo.00053.2015","article-title":"Fat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysis","volume":"309","author":"Grant","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuint.2022.105401_bib50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1046\/j.1471-4159.2001.00338.x","article-title":"Amyloid \u03b2 peptides mediate hypoxic augmentation of Ca2+ channels","volume":"77","author":"Green","year":"2001","journal-title":"J. Neurochem."},{"year":"2021","series-title":"Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults with Alzheimer's Dementia","author":"Gruber","key":"10.1016\/j.neuint.2022.105401_bib51"},{"year":"2022","series-title":"Role of Caspases, Apoptosis and Additional Factors in Pathology of Alzheimer's Disease, Human Caspases and Neuronal Apoptosis in Neurodegenerative Diseases","author":"Gupta","key":"10.1016\/j.neuint.2022.105401_bib52"},{"year":"2021","series-title":"Effects of THC-free CBD Oil on Agitation in Patients with Alzheimer's Disease","author":"Hamid Okhravi","key":"10.1016\/j.neuint.2022.105401_bib53"},{"key":"10.1016\/j.neuint.2022.105401_bib54","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2991\/jegh.k.200721.001","article-title":"Population risk factors for COVID-19 mortality in 93 countries","volume":"10","author":"Hashim","year":"2020","journal-title":"J. Epidemiol. Glob. Health"},{"key":"10.1016\/j.neuint.2022.105401_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci9100262","article-title":"Type 2 diabetes mellitus increases the risk of late-Onset Alzheimer's disease: ultrastructural remodeling of the neurovascular unit and diabetic gliopathy","volume":"9","author":"Hayden","year":"2019","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuint.2022.105401_bib56","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2022.105401_bib57","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jagp.2019.05.002","article-title":"Randomized placebo-controlled trial of nabilone for agitation in Alzheimer's disease","volume":"27","author":"Herrmann","year":"2019","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.neuint.2022.105401_bib58","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.neuint.2022.105401_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2021.664965","article-title":"Impact of COVID-19 pandemic on patients with neurodegenerative diseases","volume":"13","author":"Hu","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2022.105401_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.00261","article-title":"Pharmacotherapy of Alzheimer's disease: seeking clarity in a time of uncertainty","volume":"11","author":"Husna Ibrahim","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105401_bib61","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on \u03b2-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2022.105401_bib62","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2022.105401_bib63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JAD-181148","article-title":"Homocysteine status modifies the treatment effect of omega-3 fatty acids on cognition in a randomized clinical trial in mild to moderate Alzheimer's disease: the OmegAD Study","volume":"69","author":"Jerner\u00e9n","year":"2019","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2022.105401_bib64","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s12035-015-9260-9","article-title":"Angiotensin-(1-7) is reduced and inversely correlates with tau hyperphosphorylation in animal models of Alzheimer's disease","volume":"53","author":"Jiang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2022.105401_bib65","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1474-4422(17)30284-3","article-title":"Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study","volume":"16","author":"Josephs","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2022.105401_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1474-4422(21)00412-9","article-title":"2021 marks a new era for Alzheimer's therapeutics","volume":"21","author":"Kantarci","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2022.105401_bib67","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1021\/acs.molpharmaceut.5b00402","article-title":"Brain targeting of a water insoluble antipsychotic drug haloperidol via the intranasal route using PAMAM dendrimer","volume":"12","author":"Katare","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuint.2022.105401_bib68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/02652048.2020.1756971","article-title":"Memantine nanoemulsion: a new approach to treat Alzheimer's disease","volume":"37","author":"Kaur","year":"2020","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.neuint.2022.105401_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2020.104296","article-title":"Edible dairy formula fortified with coconut oil for neuroprotection against aluminium chloride-induced Alzheimer's disease in rats","volume":"75","author":"Khalil","year":"2020","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.neuint.2022.105401_bib70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/jcm7110407","article-title":"The role of irisin in Alzheimer's disease","volume":"7","author":"Kim","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuint.2022.105401_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13195-019-0559-z","article-title":"Gantenerumab reduces amyloid-\u03b2 plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis","volume":"11","author":"Klein","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuint.2022.105401_bib72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000486546","article-title":"A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia","volume":"45","author":"Knight","year":"2018","journal-title":"Dement. Geriatr. Cognit. Disord."},{"key":"10.1016\/j.neuint.2022.105401_bib73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainresbull.2019.01.025","article-title":"Investigation of protective effects of coenzyme Q10 on impaired synaptic plasticity in a male rat model of Alzheimer's disease","volume":"147","author":"Komaki","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuint.2022.105401_bib74","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00216-010-4631-6","article-title":"Analytical challenges in nanomedicine","volume":"399","author":"Kranz","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.neuint.2022.105401_bib75","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s11095-012-0958-3","article-title":"Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery","volume":"30","author":"Kulkarni","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuint.2022.105401_bib76","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1523\/JNEUROSCI.0485-18.2018","article-title":"Subthreshold amyloid predicts tau deposition in aging","volume":"38","author":"Leal","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2022.105401_bib77","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2174\/1567205014666170203125008","article-title":"Nanotechnology for alzheimer disease","volume":"14","author":"Leszek","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuint.2022.105401_bib78","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.2147\/IJN.S160714","article-title":"A novel albumin wrapped nanosuspension of meloxicam to improve inflammation-targeting effects","volume":"13","author":"Li","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.neuint.2022.105401_bib79","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.etap.2012.04.012","article-title":"Pharmacokinetic behavior and efficiency of acetylcholinesterase inhibition in rat brain after intranasal administration of galanthamine hydrobromide loaded flexible liposomes","volume":"34","author":"Li","year":"2012","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105401_bib80","unstructured":"Lilly, E., Mintun, F.M., Howard, R., Sha, S., n.d. News in Focus More Alzheimer \u2019 S Drugs Head for FDA Review : what Scientists Are Watching."},{"key":"10.1016\/j.neuint.2022.105401_bib81","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jinf.2020.06.072","article-title":"Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease","volume":"81","author":"Lim","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.neuint.2022.105401_bib82","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1369-7021(11)70161-4","article-title":"Carbon materials for drug delivery & cancer therapy","volume":"14","author":"Liu","year":"2011","journal-title":"Mater. Today"},{"key":"10.1016\/j.neuint.2022.105401_bib83","first-page":"242","article-title":"The Alzheimer's prevention initiative generation program: evaluating CNP520 efficacy in the prevention of Alzheimer's disease","volume":"4","author":"Lopez Lopez","year":"2017","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neuint.2022.105401_bib84","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41591-018-0275-4","article-title":"Exercise-linked FNDC5\/irisin rescues synaptic plasticity and memory defects in Alzheimer's models","volume":"25","author":"Lourenco","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2022.105401_bib85","first-page":"1","article-title":"Cerebrospinal fluid irisin correlates with amyloid-\u03b2, BDNF, and cognition in Alzheimer's disease","volume":"12","author":"Lourenco","year":"2020","journal-title":"Alzheimer\u2019s Dement. Diagnosis, Assess. Dis. Monit."},{"key":"10.1016\/j.neuint.2022.105401_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.07.213","article-title":"P4-389: ELENBECESTAT, E2609, a Bace inhibitor: results from a PHASE-2 study in subjects with mild cognitive impairment and mild-to-moderate dementia due to Alzheimer\u2019s disease","volume":"14","author":"Lynch","year":"2018","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuint.2022.105401_bib87","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/brain\/awab337","article-title":"A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene","volume":"144","author":"Magusali","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105401_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-018-05719-4","article-title":"The amyloid hypothesis on trial","volume":"559","author":"Makin","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105401_bib89","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.biomaterials.2010.10.027","article-title":"Curcumin-decorated nanoliposomes with very high affinity for amyloid-\u03b21-42 peptide","volume":"32","author":"Mourtas","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.neuint.2022.105401_bib90","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/d41586-021-01546-2","article-title":"Landmark Alzheimer's drug approval confounds research community","volume":"594","author":"Mullard","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105401_bib91","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-160742","article-title":"Levetiracetam alters oscillatory connectivity in Alzheimer's disease","volume":"58","author":"Musaeus","year":"2017","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2022.105401_bib92","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuint.2022.105401_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-30487-6","article-title":"IL-1\u03b2, IL-6, TNF- \u03b1 and CRP in elderly patients with depression or Alzheimer's disease: systematic review and meta-analysis","volume":"8","author":"Ng","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2022.105401_bib94","first-page":"1","article-title":"Cannabidiol inhibits SARS-CoV-2 replication and promotes the host innate immune response","author":"Nguyen","year":"2021","journal-title":"bioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.neuint.2022.105401_bib95","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s43587-021-00070-2","article-title":"ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease","volume":"1","author":"Novak","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neuint.2022.105401_bib96","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ibror.2019.09.019","article-title":"Improvement of cognitive functions in cadmium-induced alzheimer disease rat model after treatment with virgin coconut oil","volume":"7","author":"Nwosu","year":"2019","journal-title":"IBRO Reports"},{"key":"10.1016\/j.neuint.2022.105401_bib97","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","article-title":"A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease","volume":"9","author":"Ostrowitzki","year":"2017","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuint.2022.105401_bib98","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-\u03b2-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2022.105401_bib99","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.25410","article-title":"Amyloid-\u03b2 immunotherapy for alzheimer disease: is it now a long shot?","volume":"85","author":"Panza","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105401_bib100","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages","volume":"27","author":"Pascoal","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2022.105401_bib101","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/brain\/awaa395","article-title":"Untangling the association of amyloid-\u03b2 and tau with synaptic and axonal loss in Alzheimer's disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105401_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105314","article-title":"Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease","volume":"148","author":"Pinheiro","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"year":"2021","series-title":"Neurobiochemical Cross-Talk between COVID-19 and Alzheimer \u2019 S Disease 1017\u20131023","author":"Rahman","key":"10.1016\/j.neuint.2022.105401_bib103"},{"key":"10.1016\/j.neuint.2022.105401_bib104","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-\u03b2 in memory-impaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2022.105401_bib105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates -amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2022.105401_bib106","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1096\/fj.201600896","article-title":"Omega-3 polyunsaturated fatty acids promote amyloid-b clearance from the brain through mediating the function of the glymphatic system","volume":"31","author":"Ren","year":"2017","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuint.2022.105401_bib107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mcn.2011.09.005","article-title":"Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with \u03b2-amyloid peptide","volume":"49","author":"Rocha","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2022.105401_bib108","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-161102","article-title":"Alzheimer's disease: characterization of the brain sites of the initial tau cytoskeletal pathology will improve the success of novel immunological anti-tau treatment approaches","volume":"57","author":"R\u00fcb","year":"2017","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2022.105401_bib109","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/jcph.950","article-title":"BACE1 inhibitor lanabecestat (AZD3293) in a phase 1 study of healthy Japanese subjects: pharmacokinetics and effects on plasma and cerebrospinal fluid A\u03b2 peptides","volume":"57","author":"Sakamoto","year":"2017","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.neuint.2022.105401_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trci.2016.01.001","article-title":"Design of a Bayesian adaptive phase 2 proof-of-concept trial for BAN2401, a putative disease-modifying monoclonal antibody for the treatment of Alzheimer's disease","volume":"2","author":"Satlin","year":"2016","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.neuint.2022.105401_bib111","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41574-021-00498-x","article-title":"Brain insulin signalling in metabolic homeostasis and disease","volume":"17","author":"Scherer","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.neuint.2022.105401_bib112","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.21706","article-title":"The neuropathology of probable Alzheimer disease and mild cognitive impairment","volume":"66","author":"Schneider","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105401_bib113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2022.105401_bib114","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2174\/1567205018666210218160812","article-title":"Alzheimer's disease and its related dementia types: a review on their management via nanotechnology based therapeutic strategies","volume":"17","author":"Siafaka","year":"2021","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuint.2022.105401_bib115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-nutr-071715-050947","article-title":"Homocysteine, B vitamins, and cognitive impairment","volume":"17","author":"Smith","year":"2016","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.neuint.2022.105401_bib116","first-page":"1","article-title":"Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study","volume":"11","author":"Song","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2022.105401_bib117","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study","volume":"52","author":"Spranger","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.neuint.2022.105401_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnhum.2020.602360","article-title":"Exploiting common aspects of obesity and Alzheimer's disease","volume":"14","author":"Tabassum","year":"2020","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuint.2022.105401_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.2021-7-3","article-title":"Aducanumab: evidence from clinical trial data and controversies","volume":"10","author":"Tampi","year":"2021","journal-title":"Drugs Context"},{"key":"10.1016\/j.neuint.2022.105401_bib120","article-title":"Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer's disease","author":"Tatiparti","year":"2020","journal-title":"Drug Discov."},{"key":"10.1016\/j.neuint.2022.105401_bib121","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13195-018-0415-6","article-title":"Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study","volume":"10","author":"Timmers","year":"2018","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuint.2022.105401_bib122","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.trci.2016.08.001","article-title":"Profiling the dynamics of CSF and plasma A\u03b2 reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor","volume":"2","author":"Timmers","year":"2016","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.neuint.2022.105401_bib123","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/brain\/awx046","article-title":"Association between tau deposition and antecedent amyloid-\u03b2 accumulation rates in normal and early symptomatic individuals","volume":"140","author":"Tosun","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2022.105401_bib124","article-title":"Circulating levels of Irisin in obese individuals at genetic risk for Alzheimer's disease: correlations with amyloid-\u03b2, metabolic, and neurocognitive indices","volume":"113013","author":"Tsai","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2022.105401_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113013","article-title":"Circulating levels of Irisin in obese individuals at genetic risk for Alzheimer \u2019 s disease : correlations with amyloid- \u03b2 , metabolic , and neurocognitive indices","volume":"400","author":"Tsai","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2022.105401_bib126","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-140741","article-title":"The murine version of BAN2401 (mAb158) selectively reduces amyloid-\u03b2 protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice","volume":"43","author":"Tucker","year":"2014","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2022.105401_bib127","first-page":"1","article-title":"FDA Grants accelerated approval for Alzheimer's drug","year":"2021","journal-title":"FDA news release"},{"key":"10.1016\/j.neuint.2022.105401_bib128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","article-title":"Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease","volume":"21","author":"van der Kant","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2022.105401_bib129","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study","volume":"7","author":"Varatharaj","year":"2020","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuint.2022.105401_bib130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2012.09.038","article-title":"Cancer nanomedicines: so many papers and so few drugs","volume":"65","author":"Venditto","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuint.2022.105401_bib131","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.24794","article-title":"Incidence and impact of subclinical epileptiform activity in Alzheimer's disease","volume":"80","author":"Vossel","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2022.105401_bib132","first-page":"10","article-title":"Aducanumab for Alzheimer's disease?","volume":"374","author":"Walsh","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neuint.2022.105401_bib133","article-title":"Nanomedicine in action: an overview of cancer nanomedicine on the market and in clinical trials","author":"Wang","year":"2013","journal-title":"J. Nanomater."},{"key":"10.1016\/j.neuint.2022.105401_bib134","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13195-020-00678-3","article-title":"A phase II randomized trial of sodium oligomannate in Alzheimer's dementia","volume":"12","author":"Wang","year":"2020","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuint.2022.105401_bib135","first-page":"1","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.neuint.2022.105401_bib136","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.biomaterials.2009.09.104","article-title":"Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain","volume":"31","author":"Wang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.neuint.2022.105401_bib137","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2016.11.025","article-title":"Nanotechnology-based drug delivery systems for Alzheimer's disease management: technical, industrial, and clinical challenges","volume":"245","author":"Wen","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.neuint.2022.105401_bib138","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-170560","article-title":"Potential of low dose leuco-methylthioninium bis(Hydromethanesulphonate) (LMTM) monotherapy for treatment of mild Alzheimer's disease: cohort analysis as modified primary outcome in a phase III clinical trial","volume":"61","author":"Wilcock","year":"2017","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuint.2022.105401_bib139","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneurol.2011.221","article-title":"Autosomal recessive causes likely in early-onset alzheimer disease","volume":"69","author":"Wingo","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2022.105401_bib140","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.2147\/DMSO.S275898","article-title":"Obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications","volume":"13","author":"Wondmkun","year":"2020","journal-title":"Diabetes, Metab. Syndrome Obes. Targets Ther."},{"key":"10.1016\/j.neuint.2022.105401_bib141","unstructured":"World Alzheimer Report 2021, 2021."},{"key":"10.1016\/j.neuint.2022.105401_bib142","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.neuint.2022.105401_bib143","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000439214","article-title":"Alterations of the neuroinflammatory markers IL-6 and TRAIL in Alzheimer's disease","volume":"5","author":"Wu","year":"2015","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.neuint.2022.105401_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-021-00237-2","article-title":"COVID-19 and Alzheimer's disease: how one crisis worsens the other","volume":"10","author":"Xia","year":"2021","journal-title":"Transl. Neurodegener."},{"issue":"2","key":"10.1016\/j.neuint.2022.105401_bib145","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.atherosclerosis.2014.09.017","article-title":"Serum coenzyme Q10 and risk of disabling dementia: the circulatory risk in communities study (CIRCS)o title","volume":"237","author":"Yamagishi","year":"2014","journal-title":"Atherosclerosis Dec"},{"key":"10.1016\/j.neuint.2022.105401_bib146","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbi.2019.05.033","article-title":"Omega-3 polyunsaturated fatty acids promote brain-to-blood clearance of \u03b2-Amyloid in a mouse model with Alzheimer's disease","volume":"85","author":"Yan","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuint.2022.105401_bib147","first-page":"858","article-title":"Neuroprotection of coenzyme Q10 in neurodegenerative diseases","volume":"16","author":"Yang","year":"2016"},{"key":"10.1016\/j.neuint.2022.105401_bib148","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cpdd.422","article-title":"Clinical bioavailability of the novel BACE1 inhibitor lanabecestat (AZD3293): assessment of tablet formulations versus an oral solution and the impact of gastric pH on pharmacokinetics","volume":"7","author":"Ye","year":"2018","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.neuint.2022.105401_bib149","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1007\/s11095-015-1744-9","article-title":"Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer's disease","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuint.2022.105401_bib150","first-page":"102","article-title":"Optimal use of anatomic and metabolic brain imaging in the workup of cognitively impaired people","author":"Zukotynski","year":"2021","journal-title":"Alzheimer\u2019s Dis. Int. | World Alzheimer Rep"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018622001267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018622001267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:59:25Z","timestamp":1759312765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018622001267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":150,"alternative-id":["S0197018622001267"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105401","relation":{},"ISSN":["0197-0186"],"issn-type":[{"type":"print","value":"0197-0186"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights for Alzheimer's disease pharmacotherapy and current clinical trials","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2022.105401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105401"}}